THE PRESENT INVENTION RELATES TO AN ORODISPERSIBLE TABLET COMPRISING, BY WEIGHT: A MAXIMUM OF 15% OF A THERAPEUTICALLY ACTIVE SUBSTANCE AT LOW DOSE; FROM 55% TO 70% MANNITOL HAVING A PARTICLE SIZE BETWEEN 30 µM AND 300 µM; AT LEAST 2% MALTODEXTRIN; FROM 3.5% TO 8% OF CROSCARMELLOSE SODIUM; FROM 10% TO 20% MICROCRYSTALLINE CELLULOSE; FROM 0.5% TO 1.5% OF MAGNESIUM STARATE; AND FROM 1% TO 5% OF ONE OR MORE FLAVORS AND SWEETENERS.
展开▼
